Valuation: Center Laboratories, Inc.

Market Cap 28.41B 883M 774M 717M 660M 1.25B 84.49B 1.27B 8.55B 3.35B 41.49B 3.31B 3.24B 143B P/E 2024
-28.2x
P/E 2025 3.64x
Enterprise Value 32.45B 1.01B 884M 819M 754M 1.43B 96.51B 1.45B 9.76B 3.83B 47.4B 3.79B 3.7B 164B EV / Sales 2024
22.3x
EV / Sales 2025 23.1x
Free-Float
73.35%
Yield 2024
1.71%
Yield 2025 4.21%
1 day-2.31%
1 week-4.04%
Current month-0.26%
1 month+1.06%
3 months-4.76%
6 months-7.08%
Current year-8.53%
1 week 37.9
Extreme 37.9
40.2
1 month 36.8
Extreme 36.8
40.55
Current year 36.8
Extreme 36.8
51.4
1 year 33.1
Extreme 33.1
51.4
3 years 29.12
Extreme 29.1236
58.79
5 years 29.12
Extreme 29.1236
58.79
10 years 20.99
Extreme 20.9884
64.21
Manager TitleAgeSince
Chief Executive Officer - 02/08/1998
Director of Finance/CFO - 07/12/2022
Chief Tech/Sci/R&D Officer - 30/06/1983
Director TitleAgeSince
Chairman - 29/11/2022
Director/Board Member 61 13/06/2010
Director/Board Member - 13/06/2010
Change 5-day change 1-year change 3-year change Capi.($)
-2.31%-4.04%+5.76%-20.25% 906M
+0.02%-0.94%+48.73%+173.48% 1,060B
+0.43%-0.40%+64.70%+62.63% 619B
-0.67%-3.23%+28.72%+84.53% 438B
-1.75%-0.33%+28.33%+23.58% 333B
+0.24%-0.42%+29.19%+47.26% 282B
-1.75%-10.57%+18.27%+22.07% 267B
+0.67%+1.03%-26.81%-37.96% 218B
-1.70%-2.59%+20.17%+56.79% 196B
+0.67%+0.71%+16.45%+70.16% 161B
Average -0.57%-3.44%+23.35%+48.23% 357.48B
Weighted average by Cap. -0.26%-3.10%+35.68%+84.17%

Financials

2024 2025
Net sales 1.62B 50.28M 44.1M 40.84M 37.58M 71.08M 4.81B 72.47M 487M 191M 2.36B 189M 185M 8.16B 1.52B 47.12M 41.33M 38.28M 35.22M 66.62M 4.51B 67.91M 456M 179M 2.21B 177M 173M 7.65B
Net income -1.1B -34.3M -30.08M -27.86M -25.64M -48.49M -3.28B -49.44M -332M -130M -1.61B -129M -126M -5.57B 9.32B 290M 254M 235M 217M 410M 27.73B 418M 2.81B 1.1B 13.62B 1.09B 1.06B 47.03B
Net Debt 4.48B 139M 122M 113M 104M 197M 13.33B 201M 1.35B 529M 6.54B 523M 511M 22.6B 4.04B 126M 110M 102M 93.88M 178M 12.02B 181M 1.22B 477M 5.9B 472M 461M 20.39B
Logo Center Laboratories, Inc.
Center Laboratories Inc is a Taiwan-based company engaged in the development of pharmaceutical products. The Company's products mainly focus on internal liquids, including syrups, suspensions, liquids and other dosage forms. Pharmacological classifications include respiratory tract therapeutics such as cough suppressants, sputum expectorants, asthma medications, and runny nose relief, while antipyretic and analgesic medications and gastrointestinal medications are also in great demand, and a variety of internal liquids and lozenges for the treatment of central nervous system (CNS) such as epilepsy, dysphoria, dementia, and Parkinson's disease have already been introduced into the market. The Company is a specialized manufacturer of internal liquid.
Employees
-
Date Price Change Volume
12/07/26 NT$38.05 -2.31% 2,309,344
09/07/26 NT$38.95 -1.02% 1,354,313
08/07/26 NT$39.35 -0.38% 2,447,035
07/07/26 NT$39.50 -0.75% 2,544,596
06/07/26 NT$39.80 +0.38% 4,071,591
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
  1. Stock Market
  2. Stocks
  3. 4123 Stock